References
- https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. Accessed September 4th, 2020.
- https://covid19.who.int/. Accessed January2nd, 2021.
- Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China [published online ahead of print, 2020 Mar 31]. JAMA Ophthalmol. 2020;138(5):575–578. doi:https://doi.org/10.1001/jamaophthalmol.2020.1291.
- Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R Jr. Retinal findings in patients with COVID-19. Lancet. 2020;395(10237):1610. doi:https://doi.org/10.1016/S0140-6736(20)31014-X.
- Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi:https://doi.org/10.1080/09273948.2020.1738501.
- Acharya S, Diamond M, Anwar S, Glaser A, Tyagi P. Unique case of central retinal artery occlusion secondary to COVID-19 disease. IDCases. 2020;21:e00867. doi:https://doi.org/10.1016/j.idcr.2020.e00867.
- Dumitrascu OM, Volod O, Bose S, Wang Y, Biousse V, Lyden PD. Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban. J Stroke Cerebrovasc Dis. 2020;29(8):104982. doi:https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104982.
- Insausti-García A, Reche-Sainz JA, Ruiz-Arranz C, López Vázquez Á, Ferro-Osuna M. Papillophlebitis in a COVID-19 patient: inflammation and hypercoagulable state [published online ahead of print, 2020 Jul 30]. Eur J Ophthalmol. 2020;11206721 20947591. doi:https://doi.org/10.1177/1120672120947591.
- Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738–1742. doi:https://doi.org/10.1111/jth.14850.
- Rotzinger DC, Beigelman-Aubry C, von Garnier C, Qanadli SD. Pulmonary embolism in patients with COVID-19: time to change the paradigm of computed tomography. Thromb Res. 2020;190:58–59. doi:https://doi.org/10.1016/j.thromres.2020.04.011.
- To KF, Lo AW. Exploring the pathogenesis of severe acute respiratory syndrome(SARS): the tissue distribution of the coronavirus(SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2(ACE2). J Pathol. 2004;203(3):740–743. doi:https://doi.org/10.1002/path.1597.
- Becker RC. COVID-19 update: covid-19-associated coagulopathy. J Thromb Thrombolysis. 2020;50(1):54–67. doi:https://doi.org/10.1007/s11239-020-02134-3.
- Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. Jul 2020;191:145–147. doi:https://doi.org/10.1016/j.thromres.2020.04.013.